Corcept Therapeutics reported $94.86M in Gross Profit on Sales for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
TG Therapeutics TGTX:US 1.74M 341K
Acadia Pharmaceuticals ACAD:US $ 124.93M 14.92M
Ani Pharmaceuticals ANIP:US $ 27.65M 1.34M
Aphria Inc APH:CN C$ -7278000 20.68M
Ardelyx ARDX:US $ 1.17M 0.14M
Aurora Cannabis Inc ACB:CN 14.1M 75.17M
Biomarin Pharmaceutical BMRN:US $ 305.2M 69.43M
Bristol Myers Squibb BMY:US $ 9333M 81M
Canopy Growth Corp WEED:CN C$ -71140000 98.38M
Corcept Therapeutics CORT:US $ 94.86M 4.65M
Depomed DEPO:US $ 22.42M 0.97M
Eli Lilly And LLY:US $ 5342M 555.1M
Esperion Therapeutics ESPR:US $ 8.85M 30.01M
Gw Pharmaceuticals GWPH:US $ 140.66M 2.86M
Johnson & Johnson JNJ:US $ 16088M 343M
Knight Therapeutics Inc GUD:CN C$ 37.77M 8.9M
Lannett LCI:US $ 16.52M 6.14M
Lexicon Pharmaceuticals LXRX:US 23K 211K
Merk MRK:US $ 10098M 1738M
Nektar Therapeutics NKTR:US $ 19.61M 1.05M
Novartis NVS:US $ 9519M 21M
Novartis NOVN:VX 9.52B 21M
Omeros OMER:US $ 29.67M 1.19M
Pacira Pharmaceuticals PCRX:US $ 93.07M 7.27M
Pfizer PFE:US $ 14163M 2178M
Supernus Pharmaceuticals SUPN:US $ 130.38M 14.08M